Da. Fullerton et al., EFFECTIVE CONTROL OF REFRACTORY PULMONARY-HYPERTENSION AFTER CARDIAC OPERATIONS, Journal of thoracic and cardiovascular surgery, 113(2), 1997, pp. 363-368
Objectives: Inhaled nitric oxide is a promising therapy to control pul
monary hypertension. However, pulmonary hypertension caused by valvula
r heart disease is often refractory to inhaled nitric oxide. The objec
tive of this study was to determine whether the combination of inhaled
nitric oxide plus dipyridamole will cause a response in patients with
pulmonary hypertension undergoing cardiac operations who had not resp
onded to inhaled nitric oxide alone, Methods: Responses in 10 patients
(62 +/- 7 years) with pulmonary hypertension caused by aortic or mitr
al valvular disease (mean pulmonary artery pressure, greater than or e
qual to 30 mm Hg) were studied in the operating room after valve repla
cement. The effect of inhaled nitric oxide alone (40 ppm) on pulmonary
vascular resistance, mean pulmonary artery pressure, cardiac output,
and mean arterial pressure was determined. Inhaled nitric oxide admini
stration was then stopped and patients were given dipyridamole (0.2 mg
/kg intravenously); the effect of inhaled nitric oxide plus dipyridamo
le was then examined, Results: Dipyridamole effected a response in pat
ients who had not responded to nitric oxide, Pulmonary vascular resist
ance and mean pulmonary artery pressure were significantly reduced and
cardiac output was increased without change in mean arterial pressure
, Conclusions: Patients with refractory pulmonary hypertension in whom
inhaled nitric oxide alone fails to cause a response may respond to c
ombined therapy of inhaled nitric oxide plus dipyridamole. This therap
y may be particularly valuable in patients with dysfunction of the rig
ht side of the heart as a result of pulmonary hypertension because of
its effective lowering of right ventricular afterload.